MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2026.1821076

Медицинская библиотека · Frontiers in medicine · 2026

Helicobacter pylori and metabolic-associated fatty liver disease severity: a meta-analysis.

Zhang Lingyun, Zhang Yuexia, Qiao Lei, Wu Ruihan, He Feng, Guan Yuxin, Li Lei

СтатьяСистематический обзорПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Metabolic-associated fatty liver disease (MAFLD) is a global health concern. Observational evidence has suggested a possible relationship between Helicobacter pylori infection and MAFLD severity; however, severity-focused data remain inconsistent and methodologically heterogeneous.

METHODS

We searched the international databases PubMed, Embase and Web of Science and the Chinese databases China National Knowledge Infrastructure, Chinese Scientific Journal Database (VIP) and Wanfang between January 2015 and December 2024. Observational studies reporting H. pylori status and MAFLD/non-alcoholic fatty liver disease (NAFLD) severity were included. Studies using NAFLD criteria were considered clinically comparable with MAFLD because they were conducted before the broad adoption of the MAFLD terminology and enrolled fatty liver disease populations defined by hepatic steatosis with metabolic features. Pooled odds ratios (ORs) were calculated using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustment.

RESULTS

Seven studies, comprising 11,168 participants (4,980 H. pylori-positive; 6,188 H. pylori-negative), were included. The overall random-effects analysis did not demonstrate a statistically significant association between H. pylori infection and MAFLD severity (pooled OR 1.47, 95% confidence interval [CI]: 0.83-2.59, p = 0.148; τ 2 = 0.1325), with substantial heterogeneity (I 2 = 79.0%). In the non-invasive assessment subgroup, the pooled estimate was OR = 1.22 (95% CI: 0.95-1.57). The two biopsy-based studies showed high but highly imprecise individual estimates and were not interpreted as evidence of a stronger association. Geographic analysis showed an association only in Chinese populations (OR = 1.31, 95% CI: 1.15-1.49, I 2 = 0%).

CONCLUSION

Current evidence does not demonstrate a statistically significant overall association between H. pylori infection and MAFLD severity. A modest association was observed in Chinese studies, although biopsy-based evidence remains too imprecise for inference. Large-scale prospective studies with standardized assessment of active H. pylori infection and MAFLD severity are needed before causal or therapeutic conclusions can be drawn.

Для цитирования: Zhang Lingyun, Zhang Yuexia, Qiao Lei, Wu Ruihan, He Feng, Guan Yuxin, Li Lei. Helicobacter pylori and metabolic-associated fatty liver disease severity: a meta-analysis.. Frontiers in medicine. 2026. DOI: 10.3389/fmed.2026.1821076.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.